This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Apr;25(4):692-4.

doi: 10.1002/jbmr.69.

ASARM mineralization hypothesis: a bridge too far?

Valentin David¹, L Darryl Quarles

Affiliations

PMID: 20200985
PMCID: PMC3153325
DOI: 10.1002/jbmr.69

Comment

ASARM mineralization hypothesis: a bridge too far?

Valentin David et al. J Bone Miner Res. 2010 Apr.

. 2010 Apr;25(4):692-4.

doi: 10.1002/jbmr.69.

Authors

Valentin David¹, L Darryl Quarles

Affiliation

¹ Department of Medicine, Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

PMID: 20200985
PMCID: PMC3153325
DOI: 10.1002/jbmr.69

No abstract available

PubMed Disclaimer

Comment in

ASARM mineralization hypothesis: a bridge to progress.
Addison WN, McKee MD. Addison WN, et al. J Bone Miner Res. 2010 May;25(5):1191-2. doi: 10.1002/jbmr.110. J Bone Miner Res. 2010. PMID: 20496373 No abstract available.

Comment on

Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage.
Addison WN, Masica DL, Gray JJ, McKee MD. Addison WN, et al. J Bone Miner Res. 2010 Apr;25(4):695-705. doi: 10.1359/jbmr.090832. J Bone Miner Res. 2010. PMID: 19775205

Similar articles

Evidence for a bone-kidney axis regulating phosphate homeostasis.
Quarles LD. Quarles LD. J Clin Invest. 2003 Sep;112(5):642-6. doi: 10.1172/JCI19687. J Clin Invest. 2003. PMID: 12952909 Free PMC article.
Active sites of human MEPE-ASARM regulating bone matrix mineralization.
Minamizaki T, Sakurai K, Hayashi I, Toshishige M, Yoshioka H, Kozai K, Yoshiko Y. Minamizaki T, et al. Mol Cell Endocrinol. 2020 Nov 1;517:110931. doi: 10.1016/j.mce.2020.110931. Epub 2020 Jul 24. Mol Cell Endocrinol. 2020. PMID: 32712387
MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.
Addison WN, Nakano Y, Loisel T, Crine P, McKee MD. Addison WN, et al. J Bone Miner Res. 2008 Oct;23(10):1638-49. doi: 10.1359/jbmr.080601. J Bone Miner Res. 2008. PMID: 18597632
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD. Quarles LD. Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E1-9. doi: 10.1152/ajpendo.00016.2003. Am J Physiol Endocrinol Metab. 2003. PMID: 12791601 Review.
Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis.
Qin C, D'Souza R, Feng JQ. Qin C, et al. J Dent Res. 2007 Dec;86(12):1134-41. doi: 10.1177/154405910708601202. J Dent Res. 2007. PMID: 18037646 Review.

See all similar articles

Cited by

Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.
Quarles LD. Quarles LD. Nat Rev Endocrinol. 2012 Jan 17;8(5):276-86. doi: 10.1038/nrendo.2011.218. Nat Rev Endocrinol. 2012. PMID: 22249518 Free PMC article. Review.
Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
Martin A, David V, Li H, Dai B, Feng JQ, Quarles LD. Martin A, et al. Mol Endocrinol. 2012 Nov;26(11):1883-95. doi: 10.1210/me.2012-1062. Epub 2012 Aug 28. Mol Endocrinol. 2012. PMID: 22930691 Free PMC article.
Dentin matrix degradation by host matrix metalloproteinases: inhibition and clinical perspectives toward regeneration.
Chaussain C, Boukpessi T, Khaddam M, Tjaderhane L, George A, Menashi S. Chaussain C, et al. Front Physiol. 2013 Nov 1;4:308. doi: 10.3389/fphys.2013.00308. Front Physiol. 2013. PMID: 24198787 Free PMC article. Review.
Regulation and function of the FGF23/klotho endocrine pathways.
Martin A, David V, Quarles LD. Martin A, et al. Physiol Rev. 2012 Jan;92(1):131-55. doi: 10.1152/physrev.00002.2011. Physiol Rev. 2012. PMID: 22298654 Free PMC article. Review.

References

1. Liu S, Tang W, Zhou J, et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol. 2006;17:1305–1315. - PubMed
1. Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006;281:6120–6123. - PMC - PubMed
1. Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444:770–774. - PubMed
1. Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008;118:3820–3828. - PMC - PubMed
1. Quarles LD. Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest. 2003;112:642–646. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources